Therapeutic agent for dystrophic epidermolysis bullosa

The present disclosure pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing, for example, bulla-derived cells of a dystrophic epidermolysis bullosa patient that have been genetically engineered so as to produce type VII collagen.

Saved in:
Bibliographic Details
Main Authors TAMAI, Katsuto, TAMAKOSHI, Tomoki, KIKUCHI, Yasushi
Format Patent
LanguageEnglish
Published 16.03.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract The present disclosure pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing, for example, bulla-derived cells of a dystrophic epidermolysis bullosa patient that have been genetically engineered so as to produce type VII collagen.
AbstractList The present disclosure pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing, for example, bulla-derived cells of a dystrophic epidermolysis bullosa patient that have been genetically engineered so as to produce type VII collagen.
Author TAMAKOSHI, Tomoki
KIKUCHI, Yasushi
TAMAI, Katsuto
Author_xml – fullname: TAMAI, Katsuto
– fullname: TAMAKOSHI, Tomoki
– fullname: KIKUCHI, Yasushi
BookMark eNrjYmDJy89L5WQwC8lILUosSC0tyUxWSExPzStRSMsvUkipLC4pyi_IAAqmFmSmpBbl5udUFmcWKySV5uTkFyfyMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4x1AjAyMDE1NLCyNTR0Nj4lQBALKZMO0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020459825A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020459825A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020459825A13
Notes Application Number: AU20200459825
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230316&DB=EPODOC&CC=AU&NR=2020459825A1
ParticipantIDs epo_espacenet_AU2020459825A1
PublicationCentury 2000
PublicationDate 20230316
PublicationDateYYYYMMDD 2023-03-16
PublicationDate_xml – month: 03
  year: 2023
  text: 20230316
  day: 16
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Osaka University
RelatedCompanies_xml – name: Osaka University
Score 3.4542422
Snippet The present disclosure pertains to a composition to be used in treating dystrophic epidermolysis bullosa, said composition containing, for example,...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Title Therapeutic agent for dystrophic epidermolysis bullosa
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230316&DB=EPODOC&locale=&CC=AU&NR=2020459825A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlILSt6L9SruHIVs_GMI-kE72NpKYoqBNWSvif-8ldG5PewsJCcnB7-5-l9wF4F4Q4eSkF1qeTVW0yuZWKELP4g5BhRkQGnAV7xhPyGjuPS_8RQs-17kwuk7ojy6OiIjiiPda6-tyE8SK9dvK6oF9YJd8SrN-bDbsGP1p1yZmPOwns2k8jcwoQiZpTl7UGDovPeRDA-RKe-hIBwoPyetQ5aWU20YlPYb9Ga5X1CfQEkUHDqP132sdOBg3V97YbNBXnQLJNslSBlU5UQa6nMbbL06S5Tt2CvXf6-pL6jojBkN6KSt6BndpkkUjCzew_D_vcjDf3q17Du1CFuICDCdg3LVp_sh85uW-T1UxQaTGzCEOQ_RdQnfXSle7h6_hSElQPbCySRfa9epb3KDFrdmtFtQfi4qEMg
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWlb0X7lXYPQ7Z-UHXthnSyt9HUFAVty1oR_3svoXN72ltISEgOfnf3u-QuALeMMC0jfVsx1IRHq9RUsZltKKlGUGFaJLFSHu8IIxLMjKe5OW_B5yoXRtQJ_RHFERFRKeK9Fvq6XAexXPG2srqjH9hVPPjxwJUbdoz-tK4S2R0NvOnEnTiy4yCTlKMXPobOSx_50BC50g462RbHg_c64nkp5aZR8Q9gd4rr5fUhtFjehY6z-nutC3thc-WNzQZ91RGQeJ0sJSU8J0pCl1N6-8VJRfmOnYz_97r8KkSdEYkivSyq5BhufC92AgU3sPg_72I429ytfgLtvMjZKUiaRVNdTbJ7alIjM82EFxNEakw1olFE3xn0tq10vn34GjpBHI4X48fo-QL2uTT5YyuV9KBdL7_ZJVrfml4Jof0B6i-HJQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Therapeutic+agent+for+dystrophic+epidermolysis+bullosa&rft.inventor=TAMAI%2C+Katsuto&rft.inventor=TAMAKOSHI%2C+Tomoki&rft.inventor=KIKUCHI%2C+Yasushi&rft.date=2023-03-16&rft.externalDBID=A1&rft.externalDocID=AU2020459825A1